FINAL RESULTS OF EGFR MUTATION REANALYSIS AND KRAS MUTATION SCREENING BY SCORPION ARMS METHOD: PHASE II STUDY OF ERLOTINIB FOR EGFR WILD TYPE NON-SMALL CELL LUNG CANCER PATIENTS. CENTRAL JAPAN LUNG STUDY GROUP (CJLSG) 0903 TRIAL.

JOURNAL OF THORACIC ONCOLOGY(2013)

引用 0|浏览5
暂无评分
关键词
NSCLC
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要